Sheng Ao

CCNA2 Is a Prognostic Biomarker for ER+ Breast Cancer and Tamoxifen Resistance

Tian Gao, Yong Han, Ling Yu et al. · PLoS ONE · 2014 · 149 citations · Full text

Medicine, Cancer Biology, Oncology +16

Clinical study of harvesting lymph nodes with carbon nanoparticles in advanced gastric cancer: a prospective randomized trial

Ziyu Li, Sheng Ao, Zhaode Bu et al. · World Journal of Surgical Oncology · 2016 · 76 citations · Full text

Medicine, Oncology, Surgery +15

Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway

Runjia Fu, Xiaohong Wang, Ying Hu et al. · International Journal of Oncology · 2019 · 53 citations · Full text

Medicine, Oncology, Pharmacology +17

HOXC10 up-regulation promotes gastric cancer cell proliferation and metastasis through MAPK pathway

Chen Guo, Jianing Hou, Sheng Ao et al. · Chinese Journal of Cancer Research · 2017 · 41 citations

Medicine, Molecular Biology, Oncology +17

The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis

Kai Zhou, Anqiang Wang, Sheng Ao et al. · BMC Cancer · 2020 · 27 citations · Full text

Medicine, Clinical Sciences, Oncology +15